Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral.
DengueDiagnostic médical
#2
Quels tests pour le paludisme au Vietnam ?
Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme.
PaludismeTests de diagnostic
#3
Comment identifier la tuberculose ?
La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures.
TuberculoseDiagnostic médical
#4
Quels signes pour le choléra ?
Le choléra se diagnostique par des selles liquides et des tests de laboratoire.
CholéraDiagnostic médical
#5
Comment détecter une infection à VIH ?
Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH.
VIHDiagnostic médical
Symptômes
5
#1
Quels symptômes de la dengue ?
Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents.
DengueSymptômes
#2
Quels signes du paludisme ?
Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques.
PaludismeSymptômes
#3
Quels symptômes de la tuberculose ?
Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants.
TuberculoseSymptômes
#4
Quels signes du choléra ?
Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques.
CholéraSymptômes
#5
Quels symptômes d'une infection à VIH ?
Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés.
VIHSymptômes
Prévention
5
#1
Comment prévenir la dengue ?
Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques.
DenguePrévention
#2
Quelles mesures pour prévenir le paludisme ?
Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs.
PaludismePrévention
#3
Comment prévenir la tuberculose ?
Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention.
TuberculosePrévention
#4
Quelles précautions contre le choléra ?
Boire de l'eau potable, se laver les mains et consommer des aliments cuits.
CholéraPrévention
#5
Comment prévenir le VIH ?
Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH.
VIHPrévention
Traitements
5
#1
Quel traitement pour la dengue ?
Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate.
DengueTraitement
#2
Comment traiter le paludisme ?
Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme.
PaludismeTraitement
#3
Quel traitement pour la tuberculose ?
La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois.
TuberculoseTraitement
#4
Comment traiter le choléra ?
Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire.
CholéraTraitement
#5
Quel traitement pour le VIH ?
Le VIH est traité par des antirétroviraux pour contrôler la charge virale.
VIHTraitement
Complications
5
#1
Quelles complications de la dengue ?
Les complications incluent la dengue sévère, le choc et des hémorragies.
DengueComplications
#2
Quelles complications du paludisme ?
Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques.
PaludismeComplications
#3
Quelles complications de la tuberculose ?
Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments.
TuberculoseComplications
#4
Quelles complications du choléra ?
La déshydratation sévère peut entraîner un choc hypovolémique et la mort.
CholéraComplications
#5
Quelles complications du VIH ?
Le VIH peut mener à des infections opportunistes et à des cancers associés.
VIHComplications
Facteurs de risque
5
#1
Quels facteurs de risque pour la dengue ?
Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement.
DengueFacteurs de risque
#2
Quels facteurs de risque pour le paludisme ?
Vivre dans des zones endémiques, absence de protection contre les moustiques.
PaludismeFacteurs de risque
#3
Quels facteurs de risque pour la tuberculose ?
Conditions de vie précaires, immunodépression et contact avec des malades.
TuberculoseFacteurs de risque
#4
Quels facteurs de risque pour le choléra ?
Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés.
CholéraFacteurs de risque
#5
Quels facteurs de risque pour le VIH ?
Relations sexuelles non protégées, partage de seringues et absence de dépistage.
VIHFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vietnam : Questions médicales les plus fréquentes",
"headline": "Vietnam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vietnam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vietnam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Asie du Sud-Est",
"url": "https://questionsmedicales.fr/mesh/D001210",
"about": {
"@type": "MedicalCondition",
"name": "Asie du Sud-Est",
"code": {
"@type": "MedicalCode",
"code": "D001210",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vietnam",
"alternateName": "Vietnam",
"code": {
"@type": "MedicalCode",
"code": "D014744",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pham Quang Thai",
"url": "https://questionsmedicales.fr/author/Pham%20Quang%20Thai",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam."
}
},
{
"@type": "Person",
"name": "Le Van Tan",
"url": "https://questionsmedicales.fr/author/Le%20Van%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam."
}
},
{
"@type": "Person",
"name": "Marc Choisy",
"url": "https://questionsmedicales.fr/author/Marc%20Choisy",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "H Rogier van Doorn",
"url": "https://questionsmedicales.fr/author/H%20Rogier%20van%20Doorn",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "H T Nguyen",
"url": "https://questionsmedicales.fr/author/H%20T%20Nguyen",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Anti-immunoglobulin E for food allergy.",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37031775",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.anai.2023.03.030"
}
},
{
"@type": "ScholarlyArticle",
"name": "Omalizumab is not just an anti-immunoglobulin E.",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35723235",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09546634.2022.2089326"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advances in immunoglobulin E mediated antibiotic allergy.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36036421",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001171"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel test for type-I allergy based on crosslink formation of immunoglobulin-E receptors by allergen-specific immunoglobulin-E antibodies and an allergen.",
"datePublished": "2023-11-11",
"url": "https://questionsmedicales.fr/article/37951988",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-46730-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inborn errors of immunity associated with elevated immunoglobulin E.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35872242",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.anai.2022.07.013"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Asie",
"item": "https://questionsmedicales.fr/mesh/D001208"
},
{
"@type": "ListItem",
"position": 4,
"name": "Asie du Sud-Est",
"item": "https://questionsmedicales.fr/mesh/D001210"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vietnam",
"item": "https://questionsmedicales.fr/mesh/D014744"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vietnam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vietnam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vietnam",
"description": "Comment diagnostiquer la dengue au Vietnam ?\nQuels tests pour le paludisme au Vietnam ?\nComment identifier la tuberculose ?\nQuels signes pour le choléra ?\nComment détecter une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Immunoglobulin+E#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vietnam",
"description": "Quels symptômes de la dengue ?\nQuels signes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du choléra ?\nQuels symptômes d'une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Immunoglobulin+E#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vietnam",
"description": "Comment prévenir la dengue ?\nQuelles mesures pour prévenir le paludisme ?\nComment prévenir la tuberculose ?\nQuelles précautions contre le choléra ?\nComment prévenir le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Immunoglobulin+E#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vietnam",
"description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la tuberculose ?\nComment traiter le choléra ?\nQuel traitement pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Immunoglobulin+E#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vietnam",
"description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du choléra ?\nQuelles complications du VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Immunoglobulin+E#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vietnam",
"description": "Quels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le choléra ?\nQuels facteurs de risque pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Immunoglobulin+E#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la dengue au Vietnam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral."
}
},
{
"@type": "Question",
"name": "Quels tests pour le paludisme au Vietnam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme."
}
},
{
"@type": "Question",
"name": "Comment identifier la tuberculose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures."
}
},
{
"@type": "Question",
"name": "Quels signes pour le choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se diagnostique par des selles liquides et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Comment détecter une infection à VIH ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la dengue ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels signes du paludisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la tuberculose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes du choléra ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection à VIH ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir le paludisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Quelles précautions contre le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire de l'eau potable, se laver les mains et consommer des aliments cuits."
}
},
{
"@type": "Question",
"name": "Comment prévenir le VIH ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter le paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois."
}
},
{
"@type": "Question",
"name": "Comment traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le VIH ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH est traité par des antirétroviraux pour contrôler la charge virale."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, le choc et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation sévère peut entraîner un choc hypovolémique et la mort."
}
},
{
"@type": "Question",
"name": "Quelles complications du VIH ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH peut mener à des infections opportunistes et à des cancers associés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le paludisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones endémiques, absence de protection contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conditions de vie précaires, immunodépression et contact avec des malades."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choléra ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le VIH ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Relations sexuelles non protégées, partage de seringues et absence de dépistage."
}
}
]
}
]
}
National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam.
School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia; PathWest Laboratory Medicine, Department of Microbiology, Nedlands, WA, Australia. Electronic address: thomas.riley@uwa.edu.au.
Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
To review the safety and efficacy of anti-immunoglobulin E (IgE) monotherapy or as an adjunct to oral immunotherapy (OIT) in the treatment of IgE-mediated food allergy....
Literature searches were performed using the Excerpta Medica dataBASE, Medline, Scopus, and PubMed Central to identify articles in English related to food allergy and anti-IgE therapies, including oma...
Original research articles reviewed include interventional studies, retrospective and prospective observational studies, peer-reviewed reviews, and systematic reviews. Data were reviewed and summarize...
Here, we discuss the current anti-IgE therapies being studied as a potential treatment option for food allergy. We also review trial design, safety, and efficacy data on the use of anti-IgE therapies ...
Over the past 20 years, substantial progress has been made in understanding the potential role of anti-IgE therapies for food allergy. Anti-IgE therapies seem to be a promising option that may increas...
The mechanism of omalizumab in urticaria is not literally known. Omalizumab may affect receptors on the mast cell surface in other ways, especially other than Fc epsilon RI....
Thirty patients who were treated with omalizumab with the diagnosis of chronic urticaria were included in the study. For serum vasoactive intestinal peptide (VIP), kallikrein (KAL), and substance p (S...
While SP, KAL, and VIP values increased continuously, it was observed that the D-dimer value decreased....
This study shows that omalizumab can affect mast cells other than IgE. To the best of our knowledge, this is the first study to show the relationship between omalizumab and VIP....
The purpose of this review is to identify recent advances in our understanding and management of immunoglobulin E (IgE)-mediated antibiotic allergy....
Antibiotics remain a leading cause of fatal anaphylaxis reported to the FDA. However, recent advances have defined the features of adult and pediatric patients without true IgE-mediated allergy or any...
Recent advances in defining true IgE-mediated drug allergy have helped to identify patients unlikely to be skin-test positive. In turn, this has identified patients who can skip skin testing and proce...
Detection of allergen-specific immunoglobulin E (IgE) antibodies (Abs) in serum would allow for screening of the causative allergen in patients with type-I allergy. In this study, we developed a new a...
To review the characteristic clinical and laboratory features of inborn errors of immunity (IEI) that are associated with elevated immunoglobulin (Ig)E levels....
Primary peer-reviewed literature....
Original research articles reviewed include interventional studies, retrospective studies, case-control studies, cohort studies, and review articles related to the subject matter....
An extensive literature review was completed to allow for comprehensive evaluation of several monogenic IEI. This review includes a description of the classic clinical features, common infections, cha...
IEI should be considered in patients with elevated IgE levels, especially if they have recurrent infections, eczematous dermatitis, malignancy, lymphoproliferation, autoimmunity, or connective tissue ...
In the airway, IgE is traditionally regarded as a key mediator in allergic diseases, such as AR and allergic asthma. However, growing evidence demonstrates the importance of local IgE in airway inflam...
Our study aimed to investigate whether serum total IgE and blood eosinophils were associated with radiological features of bronchiectasis in a Chinese cohort....
We retrospectively enrolled bronchiectasis patients who visited Peking University Third Hospital from Jan 1...
A total of 125 bronchiectasis patients were enrolled, with 50.4% (63/125) female, and a mean age of 62.4 ± 14.1 years. The median serum total IgE level and blood eosinophil count were 47.7 (19.8, 123....
Our study demonstrated that serum total IgE and the blood eosinophil count were associated with the radiological extent and severity of bronchiectasis, necessitating further investigation on the role ...
Laboratory biomarkers to estimate the severity of coronavirus disease 2019 (COVID-19) are crucial during the pandemic since resource allocation must be carefully planned....
To evaluate the effects of basal serum total immunoglobulin E (IgE) levels and changes in inflammatory parameters on the clinical progression of patients hospitalised with COVID-19....
Patients hospitalised with confirmed COVID-19 were included in the study. Laboratory data and total IgE levels were measured on admission. Lymphocyte, eosinophil, ferritin, d-dimer and C-reactive prot...
The study enrolled 202 patients, of which 102 (50.5%) were males. The average age was 50.17 ± 19.68 years. Of the COVID-19 patients, 41 (20.3%) showed clinical progression. Serum total IgE concentrati...
Our single-centre pilot study determined that total IgE levels may be a negative prognostic factor for clinical progression in patients hospitalised due to COVID-19 infection. Future studies are requi...
Autoimmune diseases have a prevalence of approximately 7 to 9% and are classified as either organ-specific diseases, including type I diabetes, multiple sclerosis, inflammatory bowel disease and myast...
Prothrombotic and pro-inflammatory states are known cerebral venous thrombosis risk factors. To date, two cases of venous thrombotic events after immunoglobulin-E mediated anaphylaxis have been report...
A 51-year-old female presented with headache, language, and mental disturbance lasting for two days. Two days before the onset, she had undergone a provocative test with deflazacort to study an allerg...
The close temporal association between the anaphylactic reaction and cerebral venous thrombosis suggests that anaphylactic reaction could have been a cerebral venous thrombosis precipitating factor. I...